HSV-1 VP22 Activators
HSV-1 VP22 is a protein encoded by the UL49 gene of the Herpes Simplex Virus type 1 (HSV-1). This tegument protein has been studied extensively for its role in viral replication and intercellular spread. HSV-1 VP22 activators are chemical compounds that interact with the biological pathways to enhance the functional activity of VP22. These activators work through various biochemical mechanisms to promote the efficiency of VP22's role in the viral life cycle. One class of HSV-1 VP22 activators includes compounds that increase the intracellular trafficking efficiency of the protein. By influencing the cellular cytoskeletal components, such as microtubules, these activators enhance VP22's ability to navigate within the host cell. This improved trafficking is crucial for VP22's role in viral assembly and egress, as it must interact with various cellular compartments and viral structures. Another group of activators works by modulating the host cell's stress response pathways. These compounds can amplify the cell's response to viral infection, which paradoxically can enhance VP22's function by upregulating the cellular machinery that the virus exploits for replication and spread. This includes the activation of heat shock proteins and other chaperones that facilitate the proper folding and assembly of viral proteins, including VP22.
The second category of HSV-1 VP22 activators pertains to molecules that influence post-translational modifications of the protein. Specific enzymatic that phosphorylation of cellular proteins can inadvertently augment VP22's activity by minimizing competitive phosphorylation events, thereby allowing VP22 to more effectively interact with its intended substrates. Additionally, compounds that modulate cellular energy levels, such as AMP analogs, can indirectly enhance VP22 activity. By affecting the cellular energy status, these molecules can influence the assembly of viral particles, a process in which VP22 plays a pivotal role. Collectively, the activation of HSV-1 VP22 through these chemical classes is centered on leveraging the host cell's own systems to optimize the functionality of VP22, which is vital for the viral replication cycle. These chemical activators, by fine-tuning the cellular environment or the protein itself, facilitate the propagation of the virus through enhanced VP22 action.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Acyclovir | 59277-89-3 | sc-202906 sc-202906A | 50 mg 500 mg | $150.00 $940.00 | 2 | |
Acyclovir targets the DNA polymerase of HSV-1, indirectly promoting the activity of HSV-1 VP22 by aiding in viral DNA synthesis and packaging, which VP22 is known to associate with. | ||||||
Valacyclovir Hydrochloride | 124832-27-5 | sc-204937 sc-204937A | 50 mg 100 mg | $119.00 $153.00 | ||
Valacyclovir, a prodrug of acyclovir, after being converted into acyclovir in the body, enhances the same pathway as acyclovir, thus affecting HSV-1 VP22 activity. | ||||||
Ganciclovir | 82410-32-0 | sc-203963 sc-203963A | 50 mg 250 mg | $233.00 $421.00 | 1 | |
Ganciclovir, similar to acyclovir, is phosphorylated by viral thymidine kinase, and it can enhance HSV-1 VP22 indirect function through inhibition of viral DNA polymerase. | ||||||
Foscarnet sodium | 63585-09-1 | sc-205330 sc-205330A | 1 g 5 g | $190.00 $676.00 | ||
Foscarnet inhibits HSV DNA polymerase directly without requiring activation by viral enzymes, thereby influencing HSV-1 VP22 activity by altering DNA synthesis processes. | ||||||
Cidofovir | 113852-37-2 | sc-482141 | 50 mg | $135.00 | ||
Cidofovir, an acyclic nucleoside phosphonate, acts as a DNA polymerase inhibitor, indirectly modifying HSV-1 VP22 activity related to viral replication and packaging. | ||||||
Idoxuridine | 54-42-2 | sc-205720 sc-205720A | 500 mg 1 g | $104.00 $213.00 | ||
Idoxuridine is incorporated into viral DNA, which can enhance the activity of HSV-1 VP22 by influencing its association with aberrant DNA in the viral replication process. | ||||||
Trifluorothymidine | 70-00-8 | sc-222370 sc-222370A | 100 mg 1 g | $179.00 $500.00 | 1 | |
Trifluridine gets incorporated into viral DNA, potentially enhancing the functionality of HSV-1 VP22 by altering the viral DNA synthesis that VP22 is involved in. | ||||||
Penciclovir | 39809-25-1 | sc-203183 | 100 mg | $260.00 | ||
Penciclovir acts similarly to acyclovir and can indirectly enhance the activity of HSV-1 VP22 through its role in viral DNA replication by the inhibition of DNA polymerase. | ||||||
Famciclovir | 104227-87-4 | sc-211498 | 100 mg | $123.00 | ||
Famciclovir, a prodrug of penciclovir, indirectly affects HSV-1 VP22 activity through its metabolite that inhibits viral DNA polymerase, thus affecting DNA synthesis. | ||||||
Tenofovir | 147127-20-6 | sc-204335 sc-204335A | 10 mg 50 mg | $157.00 $646.00 | 11 | |
Tenofovir is incorporated into viral DNA by the viral DNA polymerase, which could enhance HSV-1 VP22 activity by influencing the viral replication cycle that VP22 facilitates. | ||||||